Related Experiment Video
Updated: Jun 10, 2026
07:34
Induction of Acute Ischemic Stroke in Mice Using the Distal Middle Artery Occlusion Technique
Published on: December 15, 2023
Neuroprotection in acute ischemic stroke--current status.
1Stroke unit, Department of neurology, Tel Aviv Sourasky Medical Center and The Sackler Faculty of Medicine, Tel Aviv University, Israel. eitanman1@gmail.com
Journal of Cellular and Molecular Medicine
|August 19, 2010
Summary
Neuroprotection aims to prevent nerve cell death during ischemia by blocking the ischemic cascade. Despite promising animal studies, clinical trials have failed, but hope remains for effective stroke treatments.
Area of Science:
- Neuroscience
- Ischemic Stroke Research
- Neuroprotection Strategies
Background:
- Understanding of ischemia-induced cell death mechanisms has advanced.
- Neuroprotection strategies aim to mitigate neuronal damage during ischemic events.
- The ischemic cascade involves calcium influx, free radical activation, and subsequent neuronal death.
Purpose of the Study:
- To review the reasons behind the failure of neuroprotective therapies in clinical trials for stroke.
- To discuss the challenges and potential future directions for neuroprotection research.
Main Methods:
- Review of existing literature on neuroprotection clinical trials.
- Analysis of experimental data from animal models versus human trial outcomes.
- Identification of common pitfalls and limitations in neuroprotection studies.
Main Results:
- Clinical trials of neuroprotective agents have consistently failed despite positive preclinical data.
- Key factors contributing to trial failures include complexities of the ischemic cascade and translation issues from animal models.
- Specific molecular targets within the ischemic cascade have proven difficult to modulate effectively in humans.
Conclusions:
- The failure of current neuroprotective therapies highlights the complexity of stroke pathophysiology.
- Further research is needed to identify more effective therapeutic targets and optimize treatment strategies.
- Despite setbacks, the pursuit of effective neuroprotection for stroke remains a critical area of ongoing research.
Related Concept Videos
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...